Ardelyx (ARDX) EBIT Margin (2013 - 2026)

Ardelyx (ARDX) posted EBIT Margin of 34.71% for Q1 2026, down 952.4% on a QoQ basis from 4.07% in Q4 2025, and up 1433.0% year-over-year from 2.26% in Q1 2025.

Ardelyx (ARDX) EBIT Margin (2013 - 2026) Analysis & Trends

Ardelyx's EBIT Margin history runs 12 years deep, the most recent figure standing at 34.71% for Q1 2026.

  • Quarterly EBIT Margin rose 1433.0% year-over-year to 34.71% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.67% (down 71.0% YoY) and the FY2025 annual result came in at 10.06%, down 168.0% from the prior year.
  • EBIT Margin was 34.71% for Q1 2026 at Ardelyx, down from 4.07% in the prior quarter.
  • Across five years, EBIT Margin topped out at 137.29% in Q3 2025 and bottomed at 5941.67% in Q1 2022.
  • A 5-year average of 457.82% and a median of 34.71% in 2026 frame the typical range for EBIT Margin.
  • Annual changes were most pronounced in 2022 — EBIT Margin slumped 545542 bps — and 2023, when it jumped 571241 bps.
  • Ardelyx's EBIT Margin stood at 27.49% in 2022, then slumped by 396 bps to 81.44% in 2023, then soared by 109 bps to 7.0% in 2024, then plunged by 42 bps to 4.07% in 2025, then slumped by 952 bps to 34.71% in 2026.
  • Business Quant data shows ARDX's EBIT Margin at 34.71% in Q1 2026, 4.07% in Q4 2025, and 137.29% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 16.51%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 17.83%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ardelyx 1.26 Bn 1.02 Bn 89.66 Mn -34.71%

Historic Data

Download Data
DateValue
Mar 31, 2026 -34.71%
Dec 31, 2025 4.07%
Sep 30, 2025 137.29%
Jun 30, 2025 -14.74%
Mar 31, 2025 -49.04%
Dec 31, 2024 7.00%
Sep 30, 2024 2.27%
Jun 30, 2024 -18.61%
Mar 31, 2024 -53.62%
Dec 31, 2023 -81.44%
Sep 30, 2023 13.12%
Jun 30, 2023 -74.44%
Mar 31, 2023 -229.25%
Dec 31, 2022 27.49%
Sep 30, 2022 -438.83%
Jun 30, 2022 -1,037.81%
Mar 31, 2022 -5,941.67%
Dec 31, 2021 -3,427.89%
Sep 30, 2021 -3,600.68%
Jun 30, 2021 -3,414.47%